193 related articles for article (PubMed ID: 18811689)
1. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis.
Farooque A; Moss C; Zehnder D; Hewison M; Shaw NJ
Br J Dermatol; 2009 Feb; 160(2):423-5. PubMed ID: 18811689
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase.
Karakelides H; Geller JL; Schroeter AL; Chen H; Behn PS; Adams JS; Hewison M; Wermers RA
J Bone Miner Res; 2006 Sep; 21(9):1496-9. PubMed ID: 16939409
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas.
Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M
Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.
Evans KN; Taylor H; Zehnder D; Kilby MD; Bulmer JN; Shah F; Adams JS; Hewison M
Am J Pathol; 2004 Sep; 165(3):807-13. PubMed ID: 15331405
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
6. Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications.
Shumer DE; Thaker V; Taylor GA; Wassner AJ
Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F419-21. PubMed ID: 24907163
[TBL] [Abstract][Full Text] [Related]
7. Follow-up during early infancy of newborns diagnosed with subcutaneous fat necrosis.
Akın MA; Akın L; Sarıcı D; Yılmaz I; Balkanlı S; Kurtoğlu S
J Clin Res Pediatr Endocrinol; 2011; 3(4):216-8. PubMed ID: 22155466
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-rich subcutaneous fat necrosis of the newborn: A potential mimic of infection.
Ricardo-Gonzalez RR; Lin JR; Mathes EF; McCalmont TH; Pincus LB
J Am Acad Dermatol; 2016 Jul; 75(1):177-185.e17. PubMed ID: 27157147
[TBL] [Abstract][Full Text] [Related]
9. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
10. Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d.
Correa P; Segersten U; Hellman P; Akerstrom G; Westin G
J Clin Endocrinol Metab; 2002 Dec; 87(12):5826-9. PubMed ID: 12466393
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous fat necrosis in newborn-an unusual case and review of literature.
Mitra S; Dove J; Somisetty SK
Eur J Pediatr; 2011 Sep; 170(9):1107-10. PubMed ID: 21318229
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous Fat Necrosis of the Newborn: Report of Five Cases.
Lara LG; Villa AV; Rivas MM; Capella MS; Prada F; Enseñat MA
Pediatr Neonatol; 2017 Feb; 58(1):85-88. PubMed ID: 28237247
[TBL] [Abstract][Full Text] [Related]
13. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system.
Viganò P; Lattuada D; Mangioni S; Ermellino L; Vignali M; Caporizzo E; Panina-Bordignon P; Besozzi M; Di Blasio AM
J Mol Endocrinol; 2006 Jun; 36(3):415-24. PubMed ID: 16720713
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylases involved in vitamin D metabolism are differentially expressed in murine embryonic kidney: application of whole mount in situ hybridization.
Yamagata M; Kimoto A; Michigami T; Nakayama M; Ozono K
Endocrinology; 2001 Jul; 142(7):3223-30. PubMed ID: 11416045
[TBL] [Abstract][Full Text] [Related]
15. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.
Kitanaka S; Takeyama K; Murayama A; Sato T; Okumura K; Nogami M; Hasegawa Y; Niimi H; Yanagisawa J; Tanaka T; Kato S
N Engl J Med; 1998 Mar; 338(10):653-61. PubMed ID: 9486994
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous fat necrosis of the newborn: hypercalcaemia with hepatic and atrial myocardial calcification.
Dudink J; Walther FJ; Beekman RP
Arch Dis Child Fetal Neonatal Ed; 2003 Jul; 88(4):F343-5. PubMed ID: 12819172
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia, hyperkalemia and supraventricular tachycardia in a patient with subcutaneous fat necrosis.
Bahadur KA; Johnson S; Lentzner B; Gangat M; Carlson J; Balachandar S
J Pediatr Endocrinol Metab; 2018 Mar; 31(4):469-472. PubMed ID: 29373320
[TBL] [Abstract][Full Text] [Related]
18. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous fat necrosis of the newborn presenting as circular alopecia: a novel presentation.
Xu Z; Rubin AI; Oboite M
Pediatr Dermatol; 2021 Jul; 38(4):982-983. PubMed ID: 34145911
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature.
Hicks MJ; Levy ML; Alexander J; Flaitz CM
Pediatr Dermatol; 1993 Sep; 10(3):271-6. PubMed ID: 8415307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
